Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, focusing on specialty markets. It has seven approved medicines, including five that treat the underlying cause of cystic fibrosis, one for severe sickle cell disease and transfusion dependent beta thalassemia, and one for moderate-to-severe acute pain, and maintains a clinical-stage pipeline spanning multiple additional disease areas.

Source: SEC 10-K Feb 13, 2025

Relationship details are part of the Pro plan.